[Intracameral cefuroxime injections in prophylaxis of postoperative endophthalmitis after cataract surgery: implementation and results].
BACKGROUND
The European Society for Cataract and Refractive Surgery (ESCRS) endophthalmitis study demonstrated a significant decrease in the rates of postoperative endophthalmitis with the use of intracameral cefuroxime during cataract surgery. We report the organization of the implementation of this procedure in our departments and our results after 2 years.


METHODS
All patients operated on for cataract between January 2007 and December 2008 in the ophthalmology departments of the Pellegrin University Hospital in Bordeaux and Lariboisiere University Hospital in Paris received an intracameral injection of cefuroxime at the end of the surgery. The cefuroxime was prepared in ready-for-use syringes by the hospital's central pharmacy.


RESULTS
A convenient method of preparation and conditioning cefuroxime with stable preservation lasting longer than 1 week was set up in our hospitals. Between January 2007 and December 2008, out of 3316 patients who had a cataract surgery, two presented an endophthalmitis (0.06%).


CONCLUSIONS
The intracameral cefuroxime injection at the end of the cataract surgery is a means to consider to prevent endophthalmitis. It can be implemented as a part of regular practice with appropriate preparation rules. The major barrier to its further use appears to be the lack of a commercially available preformulated preparation.
Gualino
V
V
Service d'ophtalmologie, hôpital Lariboisière, AP-HP, université Paris Diderot - Paris 7, 2, rue Ambroise-Paré, 75475 Paris cedex 10, France.
San
S
S
Guillot
E
E
Korobelnik
J-F
JF
Colin
J
J
Trout
H
H
Massin
P
P
Gaudric
A
A
Tadayoni
R
R
D019072:Antibiotic Prophylaxis; D002387:Cataract Extraction / Q000009:adverse effects*; D002444:Cefuroxime / Q000008:administration & dosage*; D009877:Endophthalmitis / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D056965:Injections, Intraocular
D002444:Cefuroxime